Scott Preiss

1.4k total citations · 1 hit paper
22 papers, 1.0k citations indexed

About

Scott Preiss is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Scott Preiss has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 7 papers in Virology and 6 papers in Infectious Diseases. Recurrent topics in Scott Preiss's work include Hepatitis B Virus Studies (6 papers), Vaccine Coverage and Hesitancy (6 papers) and Virology and Viral Diseases (5 papers). Scott Preiss is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Vaccine Coverage and Hesitancy (6 papers) and Virology and Viral Diseases (5 papers). Scott Preiss collaborates with scholars based in Australia, Belgium and United States. Scott Preiss's co-authors include Nathalie Garçon, Fernanda Tavares Da Silva, Alberta Di Pasquale, Vincent R. Harley, David A. Jans, Andrew H. A. Clayton, Anthony Argentaro, Helena Sim, Philippe Buchy and Sabine Kelly and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Virology.

In The Last Decade

Scott Preiss

22 papers receiving 1.0k citations

Hit Papers

Vaccine Adjuvants: from 1920 to 2015 and Beyond 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Preiss Australia 14 365 352 337 220 127 22 1.0k
Robin A. Robinson United States 17 787 2.2× 359 1.0× 271 0.8× 269 1.2× 138 1.1× 31 1.4k
Jingyou Yu United States 20 209 0.6× 451 1.3× 276 0.8× 823 3.7× 165 1.3× 49 1.4k
Ivana Knežević Switzerland 20 263 0.7× 408 1.2× 462 1.4× 460 2.1× 56 0.4× 63 1.5k
Robert Mischler Switzerland 11 558 1.5× 390 1.1× 309 0.9× 272 1.2× 53 0.4× 12 998
Kavita Singh India 21 282 0.8× 331 0.9× 501 1.5× 214 1.0× 239 1.9× 78 1.4k
Lars R. Haaheim Norway 23 979 2.7× 639 1.8× 264 0.8× 359 1.6× 57 0.4× 59 1.5k
Edith Jasny Germany 13 193 0.5× 412 1.2× 406 1.2× 536 2.4× 108 0.9× 20 1.1k
Pavitra Roychoudhury United States 23 461 1.3× 228 0.6× 481 1.4× 973 4.4× 169 1.3× 64 1.7k
Megan Steain Australia 23 688 1.9× 518 1.5× 391 1.2× 399 1.8× 181 1.4× 54 1.6k
Mimi Guebre‐Xabier United States 15 279 0.8× 335 1.0× 182 0.5× 277 1.3× 42 0.3× 24 858

Countries citing papers authored by Scott Preiss

Since Specialization
Citations

This map shows the geographic impact of Scott Preiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Preiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Preiss more than expected).

Fields of papers citing papers by Scott Preiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Preiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Preiss. The network helps show where Scott Preiss may publish in the future.

Co-authorship network of co-authors of Scott Preiss

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Preiss. A scholar is included among the top collaborators of Scott Preiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Preiss. Scott Preiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chi‐Chang, et al.. (2023). Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults. Current Medical Research and Opinion. 40(1). 125–140. 6 indexed citations
2.
Borrow, Ray, Federico Martinón‐Torres, Véronique Abitbol, et al.. (2023). Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness. Expert Review of Vaccines. 22(1). 738–748. 2 indexed citations
3.
Bekkat-Berkani, Rafik, et al.. (2022). Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB. Journal of Infection. 85(5). 481–491. 12 indexed citations
4.
Quiambao, Beatriz P., et al.. (2020). Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines. International Journal of Infectious Diseases. 97. 38–46. 7 indexed citations
5.
Buchy, Philippe, Selim Badur, George Kassianos, Scott Preiss, & John S. Tam. (2019). Vaccinating pregnant women against influenza needs to be a priority for all countries: An expert commentary. International Journal of Infectious Diseases. 92. 1–12. 33 indexed citations
6.
Preiss, Scott, Pornthep Chanthavanich, Lin H. Chen, et al.. (2018). Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis. Expert Review of Vaccines. 17(6). 525–545. 20 indexed citations
7.
Buchy, Philippe, Scott Preiss, Ved Pal Singh, & Piyali Mukherjee. (2017). Heterogeneity of Rabies Vaccination Recommendations across Asia. Tropical Medicine and Infectious Disease. 2(3). 23–23. 14 indexed citations
8.
Sampath, Gadey, Angelika Banzhoff, Alaka Deshpande, et al.. (2017). Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study. Human Vaccines & Immunotherapeutics. 13(7). 1531–1538. 5 indexed citations
9.
Hardt, Karin, Paolo Bonanni, Susan Codi King, et al.. (2016). Vaccine strategies: Optimising outcomes. Vaccine. 34(52). 6691–6699. 87 indexed citations
10.
Preiss, Scott, Nathalie Garçon, Anthony L. Cunningham, Richard A. Strugnell, & Leonard R. Friedland. (2016). Vaccine provision: Delivering sustained & widespread use. Vaccine. 34(52). 6665–6671. 25 indexed citations
11.
Pasquale, Alberta Di, Scott Preiss, Fernanda Tavares Da Silva, & Nathalie Garçon. (2015). Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines. 3(2). 320–343. 466 indexed citations breakdown →
12.
Shaw, Timothy J., Margaret Littlejohn, Danni Colledge, et al.. (2012). In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection. Journal of Medical Virology. 84(8). 1166–1176. 10 indexed citations
13.
Woollard, David J., Catriona McLean, Scott Preiss, et al.. (2011). Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. Journal of Hepatology. 55(3). 536–544. 15 indexed citations
14.
Roberts, Stuart K., Scott Preiss, David J. Woollard, et al.. (2010). Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection. Journal of Viral Hepatitis. 18(12). 852–860. 42 indexed citations
15.
Preiss, Scott, Margaret Littlejohn, Peter Angus, et al.. (2008). Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance. Hepatology. 48(3). 741–749. 19 indexed citations
16.
Preiss, Scott, A. Thompson, Paul Desmond, et al.. (2008). Characterization of the innate immune signalling pathways in hepatocyte cell lines. Journal of Viral Hepatitis. 15(12). 888–900. 63 indexed citations
17.
Thompson, Katherine A., Stephen J. Kent, Michelle E. Gahan, et al.. (2003). Decreased Neurotropism of nef Long Terminal Repeat ( nef /LTR)-Deleted Simian Immunodeficiency Virus. Journal of NeuroVirology. 9(4). 442–451. 17 indexed citations
18.
Kent, Stephen J., C. Jane Dale, Scott Preiss, & Damian F. J. Purcell. (2002). Evidence of Recombination between 3′ and 5′ LTRs in Macaques Inoculated with SIV DNA. AIDS Research and Human Retroviruses. 18(3). 227–230. 9 indexed citations
19.
Preiss, Scott, Anthony Argentaro, Andrew H. A. Clayton, et al.. (2001). Compound Effects of Point Mutations Causing Campomelic Dysplasia/Autosomal Sex Reversal upon SOX9 Structure, Nuclear Transport, DNA Binding, and Transcriptional Activation. Journal of Biological Chemistry. 276(30). 27864–27872. 72 indexed citations
20.
Kent, Stephen J., et al.. (2001). Vaccination with Attenuated Simian Immunodeficiency Virus by DNA Inoculation. Journal of Virology. 75(23). 11930–11934. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026